Frazier Life Sciences Management, LP
frazierls.com Direct investor
Frazier Life Sciences is a biotech investment firm managing venture capital and public equity strategies. It invests in and builds product-focused companies developing novel therapeutics, from seed stage to public companies.
Frazier Life Sciences Management, LP is a venture capital firm headquartered in Palo Alto, United States. It invests directly in companies, from seed to growth, in biotech, therapeutics and pharmaceuticals. $6.9B+ under management, as it reports.
“Frazier Life Sciences is a longstanding biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.”
— Frazier Life Sciences Management, LP, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Palo Alto, United States
- Invests in
- US
- Sectors
- biotech, therapeutics, pharmaceuticals
- Assets under management
- $6.9B+
Team, as Frazier Life Sciences Management, LP publishes it
- Albert Cha Managing Partner
- James N. Topper Managing Partner
- Patrick Heron Managing Partner
- Daniel Estes General Partner
- James W. Brush General Partner and Portfolio Manager
- Aditya Kohli Partner
- Anna H. Chen Partner
- Joe Cabral Partner
- Kevin Li Partner
- Angel Martin Vice President
- Kiah Williams Vice President
- Lin Mu Vice President
Names and roles exactly as listed on frazierls.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 53 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- RA Capital Management 10 shared companies: hillevax.com, alentis.ch, angitiabio.com, arcutis.com…
- OrbiMed 10 shared companies: alentis.ch, aspenneuroscience.com, discmedicine.com, angitiabio.com…
- Aisling Capital Management LP 6 shared companies: veronapharma.com, bridgebio.com, chimerix.com, gondolabio.com…
- Longitude Capital 6 shared companies: alentis.ch, campfieldtx.com, mirumpharma.com, collegiumpharma.com…
- Avoro Capital Advisors LLC 6 shared companies: acerta-pharma.com, aviditybiosciences.com, scorpiontx.com, amicusrx.com…
- Bain Capital Life Sciences 6 shared companies: newamsterdampharma.com, discmedicine.com, angitiabio.com, arcutis.com…
- Atlas Venture 5 shared companies: diagonaltx.com, discmedicine.com, vimatx.com, akerotx.com…
- EcoR1 Capital 5 shared companies: diagonaltx.com, scorpiontx.com, collegiumpharma.com, bridgebio.com…
- Viking Global Investors LP 5 shared companies: star-therapeutics.com, bridgebio.com, architecttherapeutics.com, gondolabio.com…
- venBio Partners LLC 4 shared companies: veronapharma.com, parabilismed.com, akerotx.com, 35pharma.com
and 43 more — the graph.
Where this comes from
Every fact above was read from a page Frazier Life Sciences Management, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://frazierls.com/name, is_investor, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, aum, status
- https://frazierls.com/strategy/layer, type
- https://frazierls.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 5297 · added 2026-09-03 · link last verified 2026-10-21 · confidence high
Similar investors
- Remiges VenturesVenture capital · Seattle, United States
- Samsara BioCapital, LLCVenture capital · Series A – Series C+ · Palo Alto, United States
- TCG Crossover Management, LLCVenture capital · Palo Alto, United States
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Avalon BioVentures Management, LLCVenture capital · Pre-seed – Seed · San Diego, United States
- Boutique Venture PartnersVenture capital · Pre-seed – Series A · Palo Alto, United States